The Relationship Between Echocardiographic Parameters With Major Cardiovascular Events In Patients With Acute Myocardial Infarction ST Elevation At H Adam Malik Hospital Medan

by ADMIN 176 views

Introduction

Acute myocardial infarction (AMI) is a serious medical condition that requires prompt diagnosis and treatment. Echocardiography is a non-invasive imaging technique that has become an essential tool in the assessment and management of patients with AMI. The relationship between echocardiographic parameters and major cardiovascular events (MACE) in patients with acute ST-elevation myocardial infarction (STEMI) is a critical area of research that can help clinicians identify high-risk patients and provide optimal treatment strategies.

Background

Echocardiography is a widely used imaging modality in clinical practice due to its ease of use, non-invasive nature, and effectiveness in assessing cardiac function. In patients with AMI, echocardiography can provide valuable information on left ventricular function, wall motion abnormalities, and other cardiac parameters that can predict the risk of MACE. The American College of Cardiology and the American Heart Association recommend the use of echocardiography in the assessment of patients with AMI to guide treatment decisions.

Methodology

This prospective study was conducted at H Adam Malik Hospital Medan from November 22 to December 22, 2015. A total of 65 patients with confirmed STEMI diagnosis were enrolled in the study. All patients underwent echocardiographic examination within 24 hours after arriving at the hospital to assess left ventricular ejection fraction (EF), wall motion score index (WMSI), systolic excursion of the tricuspid annulus (Tapse), and fractional change in the right ventricular area (RVFAC).

Results

The results of this study showed a significant relationship between several echocardiographic parameters and MACE in patients with STEMI. The parameters that showed significant relationships with MACE were:

  • Diastolic left ventricular diameter (LVEDD)
  • Left ventricular systolic diameter (Lvesd)
  • Posterior diastolic wall thickness (PWD)
  • Posterior systolic wall thickness (PWS)
  • WMSI
  • EF Simpson
  • RVFAC

These parameters were associated with various MACE, including death, arrhythmia, cardiogenic shock, and heart failure.

Discussion

The findings of this study highlight the importance of echocardiographic parameters in predicting MACE in patients with STEMI. The parameters identified in this study can help clinicians identify high-risk patients and provide optimal treatment strategies. The use of echocardiography in the assessment of patients with STEMI can help reduce the risk of MACE and improve patient outcomes.

Conclusion

In conclusion, this study demonstrates the relationship between echocardiographic parameters and MACE in patients with STEMI. The findings of this study suggest that echocardiographic examination can be a valuable tool in identifying high-risk patients and providing optimal treatment strategies. Further studies are needed to confirm these findings and investigate the role of echocardiographic parameters in determining optimal treatment strategies for STEMI patients.

Recommendations

Based on the findings of this study, the following recommendations are made:

  • Echocardiographic examination must be done on all STEMI patients within 24 hours after arriving at the hospital.
  • Echocardiographic parameters such as EF Simpson, WMSI, RVFAC, and Tapse must be considered in the assessment of MACE risk in STEMI patients.
  • Further studies are needed to confirm these findings and investigate the role of echocardiographic parameters in determining optimal treatment strategies for STEMI patients.

Benefits of Articles

This article provides important information about the role of echocardiography in STEMI patient management. This article also highlights the need for further research to increase our understanding of the relationship between echocardiographic parameters and MACE in STEMI patients.

Limitations

This study has several limitations, including the relatively small sample size and limited long-term follow-up data. Further studies with larger samples and longer follow-up data are needed to confirm these findings.

Future Directions

Future studies should focus on investigating the role of echocardiographic parameters in determining optimal treatment strategies for STEMI patients. Additionally, further research is needed to confirm the findings of this study and increase our understanding of the relationship between echocardiographic parameters and MACE in STEMI patients.

Conclusion

In conclusion, this study demonstrates the relationship between echocardiographic parameters and MACE in patients with STEMI. The findings of this study suggest that echocardiographic examination can be a valuable tool in identifying high-risk patients and providing optimal treatment strategies. Further studies are needed to confirm these findings and investigate the role of echocardiographic parameters in determining optimal treatment strategies for STEMI patients.

Q: What is the purpose of this study?

A: The purpose of this study is to investigate the relationship between echocardiographic parameters and major cardiovascular events (MACE) in patients with acute ST-elevation myocardial infarction (STEMI).

Q: What are the echocardiographic parameters that were studied?

A: The echocardiographic parameters that were studied include left ventricular ejection fraction (EF), wall motion score index (WMSI), systolic excursion of the tricuspid annulus (Tapse), and fractional change in the right ventricular area (RVFAC).

Q: What were the results of the study?

A: The results of the study showed a significant relationship between several echocardiographic parameters and MACE in patients with STEMI. The parameters that showed significant relationships with MACE were:

  • Diastolic left ventricular diameter (LVEDD)
  • Left ventricular systolic diameter (Lvesd)
  • Posterior diastolic wall thickness (PWD)
  • Posterior systolic wall thickness (PWS)
  • WMSI
  • EF Simpson
  • RVFAC

Q: What are the implications of the study's findings?

A: The findings of the study suggest that echocardiographic examination can be a valuable tool in identifying high-risk patients and providing optimal treatment strategies. The use of echocardiography in the assessment of patients with STEMI can help reduce the risk of MACE and improve patient outcomes.

Q: What are the limitations of the study?

A: The study has several limitations, including the relatively small sample size and limited long-term follow-up data. Further studies with larger samples and longer follow-up data are needed to confirm these findings.

Q: What are the recommendations based on the study's findings?

A: Based on the findings of the study, the following recommendations are made:

  • Echocardiographic examination must be done on all STEMI patients within 24 hours after arriving at the hospital.
  • Echocardiographic parameters such as EF Simpson, WMSI, RVFAC, and Tapse must be considered in the assessment of MACE risk in STEMI patients.
  • Further studies are needed to confirm these findings and investigate the role of echocardiographic parameters in determining optimal treatment strategies for STEMI patients.

Q: What are the benefits of the study's findings?

A: The study's findings provide important information about the role of echocardiography in STEMI patient management. The study also highlights the need for further research to increase our understanding of the relationship between echocardiographic parameters and MACE in STEMI patients.

Q: What are the future directions for research based on the study's findings?

A: Future studies should focus on investigating the role of echocardiographic parameters in determining optimal treatment strategies for STEMI patients. Additionally, further research is needed to confirm the findings of this study and increase our understanding of the relationship between echocardiographic parameters and MACE in STEMI patients.

Q: What are the potential applications of the study's findings?

A: The study's findings have potential applications in the clinical management of STEMI patients. The use of echocardiography in the assessment of patients with STEMI can help reduce the risk of MACE and improve patient outcomes.

Q: What are the potential limitations of the study's findings?

A: The study's findings are limited by the relatively small sample size and limited long-term follow-up data. Further studies with larger samples and longer follow-up data are needed to confirm these findings.

Q: What are the potential implications of the study's findings for clinical practice?

A: The study's findings have potential implications for clinical practice, including the use of echocardiography in the assessment of patients with STEMI. The study's findings also highlight the need for further research to increase our understanding of the relationship between echocardiographic parameters and MACE in STEMI patients.

Q: What are the potential implications of the study's findings for future research?

A: The study's findings have potential implications for future research, including the need for further studies to confirm the findings of this study and increase our understanding of the relationship between echocardiographic parameters and MACE in STEMI patients.